GSK Calls For Preemption Ruling In Zofran Birth Defect MDL
By Mike Curley · July 19, 2019, 4:08 PM EDT
GlaxoSmithKline has renewed its bid to end multidistrict litigation in Massachusetts federal court over claims it didn't warn customers about alleged birth defects resulting from its anti-nausea medication, saying a recent...
To view the full article, register now.